MDK and neoplasm: Furthermore, we found that s‐MDK levels decreased following treatment in patients with high s‐MDK secretion; in one case (Figure S1A), increased s‐MDK levels were detected before disease progression as determined based on imaging and the analysis of tumor markers, indicating that it could serve as a predictive factor for disease progression during treatment.